We are open to exploring partnerships.
If your company wishes to partner with Sarborg, we want to hear from you. We actively collaborate across signature analysis, agent-driven screening, licensing, databases, academic research, and commercial programmes - and we are open to exploring what a partnership could look like in all of these areas and beyond.
Where we work with partners.
Signature Analysis
Run your compounds, assets, or targets through the Signature Agent. We compare your molecules against our proprietary signature libraries to surface repurposing and combination opportunities you may not see internally.
Agent-Driven Screening
Deploy our multi-agent evaluation system across your pipeline. From deal-breaker checks through commercial, R&D, IP, and solid-form analysis, our agents continuously evaluate assets to identify opportunities worth advancing.
Asset Portfolio Licensing
License from our portfolio of solid-form and cocrystal patents, including cannabinoid assets and our cystic fibrosis assets. We work with partners to take these assets forward through development and commercialisation.
Database Usage
Gain access to our proprietary signature databases, including around 7,000 bacterial signatures, approximately 300 veterinary signatures, and around 15 proprietary Sarborg drug signatures, for your own discovery programmes.
Academic Partnerships
Collaborate with our team on research across bacterial, veterinary, agrichemical, and rare disease signature intelligence. We support academic partners with data, tooling, and joint publication opportunities.
Commercial Collaborations
Co-develop commercial programmes built on signature intelligence. From agrichemical and veterinary applications to pharma pipelines, we structure collaborations that put our platform to work on your commercial goals.
If it involves signatures, let us talk.
Sarborg is actively open to partnership conversations. Whether you are a pharmaceutical or biotech company looking to unlock underrealised value in your portfolio, an agrichemical or veterinary business exploring new indications, an academic group with a research question, or an investor-backed team seeking exclusive insight into a pipeline - our signature intelligence platform is built to work with partners.
There is no fixed model. We structure engagements around the opportunity: a single signature run, an ongoing screening programme, an exclusive licence, or a long-term commercial collaboration. The first step is simply a conversation.
Start the conversation.
Email us at info@sarborg.com or send a message through our contact page, and tell us how you would like to partner.